Rss Feed
Study clarifies the complex interaction between gut bacteria and common gastrointestinal disorder
Research from the University of Gothenburg, Sweden, clarifies the complex interaction between gut bacteria and IBS.
Earlier menopause and reduced cardiac function may negatively affect brain health
Women face a higher risk of developing both cardiovascular disease and Alzheimer's disease than men. Cardiovascular disease is linked to an increased likelihood of Alzheimer's disease, especially among women.
New study offers hope for patients with treatment-resistant focal epilepsy
About one-third of patients with focal epilepsy, a common form of the neurological disorder, are believed to respond poorly to available therapies.
Researchers develop a new approach for treating children with neuroblastoma
A research team from the University of Zurich and the University Children's Hospital Zurich has developed a new approach for treating children with malignant tumors of the nervous system.
Study provides a new approach for the treatment of prostate tumors
An international research team led by the Medical University of Vienna has demonstrated for the first time that thyroid hormone plays a key role in the development and progression of prostate cancer.
Baby's birthweight increases risk of cardiovascular disease in preeclamptic and hypertensive women
A new study shows that preeclamptic and hypertensive pregnant women's risk of getting cardiovascular disease is linked to their baby's birthweight.
Study offers a nuanced understanding of how bedroom ventilation affects sleep health
Good sleep is key to good health, overall well-being, and optimal cognitive function. Disturbed sleep or lack of sleep can lead to various health issues such as cardiovascular diseases, cancer, and other morbidity, including Alzheimer's disease and obesity.
Giles introduces AI agent to accelerate healthcare and life science research
giles AI, a company making advanced research tools accessible to all and simplifying how scientists work with data, has announced the commercial launch of giles, its AI specialised research agent designed to support healthcare, clinical, and medical research.
AI system watches kids eat to reveal how bite habits predict obesity risk
This study introduces ByteTrack, an AI system that analyzes bite behavior in children, offering new strategies for obesity prevention at the dinner table.
BMAC treatment accelerates healing for ACL, MCL, and meniscus tears
Bone marrow aspirate concentrate (BMAC) is a common treatment for joint injuries.
Tailored deep brain stimulation offers new hope for hard-to-treat epilepsy
Doctors and researchers at the University of Pittsburgh and UPMC have developed a new treatment for epilepsy patients who don't respond to medication and aren't candidates for surgery. Their approach, published today in Nature Communications, uses deep brain stimulation (DBS) that is tailored to each patient's unique brain wiring.
Blood proteins reveal MS immune system attack starts years before symptoms
By the time patients start seeking care for multiple sclerosis (MS), the disease has already been damaging their brains for years. But until recently, scientists didn't understand which brain cells were being targeted or when the injury began.
AGA updates guidelines for Barrett's Esophagus to catch cancer early
The American Gastroenterological Association (AGA) released a new clinical practice guideline on the surveillance of Barrett's esophagus, the only known precursor to esophageal cancer (adenocarcinoma), a highly lethal cancer whose incidence has risen substantially over recent decades.
Researchers discover how a brain circuit allows eating despite anxiety
How do mammals manage to eat in situations that cause anxiety, step into exposed spaces, or slow down when anxiety drives them to keep moving? A new study pinpoints a leptin-sensitive circuit in the lateral hypothalamus that helps to overcome anxiety to perform essential behaviors such as exploring, feeding, and limiting maladaptive hyperactivity.
Economic growth drives disparities in global cancer research
New research reveals that the number and complexity of cancer clinical trials since 2001 have varied across low- and middle-income countries (LMICs), with economic growth contributing to disparities, but only to a certain extent. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.
Molecular evidence connects higher childhood cognitive function to longer lifespan
Researchers led by Dr. W. David Hill at the University of Edinburgh have identified a significant genetic correlation between childhood cognitive function and longevity, providing the first molecular genetic evidence that intelligence measured in youth shares genetic factors with lifespan.
Study suggests earlier start of hormone therapy optimizes long-term health outcomes
Menopause may take a toll on women physically and emotionally due to declining estrogen levels. For some, the use of hormone therapy has proven valuable in managing bothersome menopause symptoms.
Genetic and inflammatory factors amplify the link between earlier menopause and cognitive risk
Women are significantly more likely than men to develop Alzheimer's disease. Earlier age at menopause is associated with a greater risk for late-life cognitive decline and Alzheimer's disease.
Hormone therapy does not consistently reduce menopause-related anxiety, new review finds
Anxiety is a common and significant symptom of menopause and perimenopause, largely due to hormone fluctuations. Numerous studies have focused on the potential benefits of hormone therapy in reducing anxiety.
Largest trial of adjuvant pembrolizumab in Merkel cell carcinoma reports key benefit
A new cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) shows that a drug that utilizes the body's immune system to target and eliminate cancer cells appeared to reduce the risk of distant metastases for an aggressive form of skin cancer when given immediately after surgery, but did not significantly reduce the overall risk of recurrence, which was a co-primary endpoint of the trial.